Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Medexus Pharmaceuticals Inc (MDP.VN)

Medexus Pharmaceuticals Inc (MDP.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Complete Response Letter Received from FDA for Treosulfan

Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF) and medac GmbH ("medac") announced today that medac, Medexus' licensor for treosulfan, has received a Complete Response...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 3.13 (-3.99%)
MEDXF : 2.4400 (-4.31%)
Medexus Appoints New Chief Financial Officer

Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad as Chief Financial Officer of the Company, effective immediately....

MDP.VN : 7.750 (-4.91%)
MDP.TO : 3.13 (-3.99%)
MEDXF : 2.4400 (-4.31%)
CDNA : 64.57 (-5.00%)
Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in Canada

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSX: MDP) (OTCQX: MEDXF) today announced that it has entered into a licensing agreement, formalizing its relationship with medac GmbH ("medac")...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 3.13 (-3.99%)
MEDXF : 2.4400 (-4.31%)
Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSX: MDP) (OTCQX: MEDXF) today announced that it has received a Notice of Compliance ("NOC") from Health Canada to commercialize treosulfan, developed...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 3.13 (-3.99%)
MEDXF : 2.4400 (-4.31%)
Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021

Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021

MDP.VN : 7.750 (-4.91%)
MDP.TO : 3.13 (-3.99%)
MEDXF : 2.4400 (-4.31%)
Medexus Announces Graduation to the Toronto Stock Exchange

Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSXV:MDP) (OTCQX: MEDXF) announced today that it has received final approval for listing of the Company's common shares (the "Common Shares")...

MDP.VN : 7.750 (-4.91%)
MEDXF : 2.4400 (-4.31%)
Medexus to Present at Raymond James Human Health Innovation Conference

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it will be presenting at the Raymond James Human Health Innovation Conference...

MDP.VN : 7.750 (-4.91%)
MEDXF : 2.4400 (-4.31%)
Medexus Schedules Fiscal Year 2021 Conference Call

June 11, 2021 - Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it plans to host a conference call at 8:00 AM Eastern Time on...

MDP.VN : 7.750 (-4.91%)
MEDXF : 2.4400 (-4.31%)
Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it has expanded its medical affairs team in preparation for the planned launch...

MDP.VN : 7.750 (-4.91%)
MEDXF : 2.4400 (-4.31%)
Medexus Announces Availability of Triamcinolone Hexacetonide in the United States

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it is initiating immediate availability of Triamcinolone Hexacetonide Injectable...

MDP.VN : 7.750 (-4.91%)
MEDXF : 2.4400 (-4.31%)

Barchart Exclusives

Meats Experience Seasonal Weakness After A Bullish WASDE report
It is the offseason for animal protein demand, and prices have been moving lower over the past weeks. Meanwhile, the latest WASDE report was not bearish for beef and pork prices. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar